Compare Dominion Energy Inc (D) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dominion Energy Inc vs Sana Biotechnology Inc — how do they compare? Dominion Energy Inc trades at $68.19 (market cap $59.90B), while Sana Biotechnology Inc trades at $3.79 (market cap $1.13B). The key difference: Dominion Energy Inc is far larger — about 53× Sana Biotechnology Inc's market cap, and Dominion Energy Inc pays a 3.92% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| D | SANA | |
|---|---|---|
Market Cap | $59.90B | $1.13B |
Sector | Utilities | Health |
52-Week High | $71.67 | $5.92 |
52-Week Low | $57.08 | $2.68 |
Enterprise Value | $114.01B | $1.05B |
Dividend Yield | 3.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dominion Energy (D) trades at $67.96, up 1.23% today, with a bearish technical signal and mixed analyst sentiment. Recent Q2 2026 earnings beat estimates ($0.79 vs. $0.681 expected), driven by Virginia utility strength and data center demand, while revenue grew to $16.51B in 2025. The stock faces headwinds from high debt levels and rising operating costs, offset by stable dividends and reaffirmed 2026 guidance.
The outlook is cautious; Dominion benefits from essential service demand and dividend consistency, but valuation appears fair with a P/E of 23.56, and risks include execution on capital projects and regulatory pressures. Analyst consensus leans Hold with a $70.43 price target, suggesting limited near-term upside from current levels.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dominion Energy Inc
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
